AdamFinnBinderMD

Oncology • Philadelphia, PA

Hematologic Oncology

Assistant Professor; Sidney Kimmel Cancer Center; Thomas Jefferson University

Join to view full profile

Dr. Binder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Binder's full profile

Already have an account?

Office
925 Chestnut St
Ste 320A
Philadelphia, PA 19107
Phone+1 215-955-8874

Fax+1 215-955-2340

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2013 - 2016
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2010 - 2013
Albert Einstein College of MedicineClass of 2010

Certifications & Licensure

DE State Medical License 2019 - 2025
NJ State Medical License 2019 - 2025
NY State Medical License 2013 - 2025
PA State Medical License 2018 - 2024
MA State Medical License Active through 2013
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Exercise Prescription for the Improvement of Quality of Life in Elderly Patients With Multiple Myeloma Start of enrollment: 2019 Oct 24
Completed
Not Applicable
Home Based Daratumumab Administration for Patients With Multiple Myeloma Start of enrollment: 2022 Nov 08
Active, not recruiting
Early Phase 1
Roles: Contact

Publications & Presentations

PubMed

15 citations
Hispanic ethnicity is associated with younger age at presentation but worse survival in acute myeloid leukemia.
Karine Darbinyan, Aditi Shastri, Anjali Budhathoki, Daniel Helbig, Rose Snyder
Blood Advances. 2017-11-14
2 citations
Implementation of an Outpatient HD-MTX Initiative.
Kelsey Sokol, Kelley Yuan, Maria Piddoubny, Ellen Sweeney, Anne Delengowski
Frontiers in Oncology. 2021-01-01
3 citations
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and ...
Dolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, John L. Wagner, William O'Hara
Biology of Blood and Marrow Transplantation. 2020-10-01

Lectures

ASH Choosing Wisely® Campaign: 2018 ASH Choosing Wisely Champions
60th American Society of Hematology Annual Meeting - 12/3/2018

Press Mentions

Optimal Antibiotics Timing ‘Likely Differs’ Among Inpatients with Cancer, Neutropenic FeverMarch 9th, 2023
Delaying Antibiotics for Neutropenic Fever May Not Affect Survival of Cancer PatientsJanuary 1st, 2023
Delaying Antibiotics May Not Impact Cancer Patient SurvivalDecember 30th, 2022
Join now to see all